COPD, Telerehabilitation
Conditions
Brief summary
Pulmonary rehabilitation (PR) is a first-line management strategy in chronic obstructive pulmonary patients (COPD) as it reduces shortness of breath, increases exercise capacity, and improves health-related quality of life. However, 8-50% of patients referred to PR do not participate at all, while 10-32% of those who start do not complete the program. Barriers to participation and completion include difficulty in accessing the program, poor mobility, lack of transport, and travel costs. Telerehabilitation is defined as the provision of rehabilitation services through telecommunication technology, including telephone, internet and video conference communications between the patient and the healthcare provider. Different technologies (from phone to video conferencing) have been tested in patients with COPD to enhance daily activities, exercise training and walking prescription. All of them showed positive effects on exercise tolerance, dyspnea, physical activity and quality of life. However, there is no study about which telerehabilitation program is more effective on COPD patients. The aim of this study is to investigate which telerehabilitation approach is more effective in COPD.
Interventions
Exercises will be done 3 days a week for 6 weeks, with the help of a physiotherapist via video conference.
The exercise video will be sent to the patients and they will do it 3 days a week for 6 weeks. The subjects will be asked to keep an exercise diary and the status of the diaries will be followed by calling once a week.
Sponsors
Study design
Eligibility
Inclusion criteria
* Being diagnosed with COPD (FEV1 / FVC \<70% in the stable phase of the disease) * Age \> 18 years old * Have the ability to use a smartphone
Exclusion criteria
* Musculoskeletal disorders that limit exercise * Dizziness, significant sensory or motor impairments, dementia or terminal illnesses that prevent education * Serious comorbidities such as unstable heart disease, irregular diabetes, known malignant disease, any other disease that makes the patient unsuitable for participation in the study. * Incompatible patient * Severe vision or hearing impairment * Unwillingness or inability to follow the protocol * Have had a COPD exacerbation in the previous 6 weeks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 6 minute walk test(6MWT) | 6 week |
| Pulmonary function testing | 6 week |
Secondary
| Measure | Time frame |
|---|---|
| 30-Second Chair Stand Test | 6 week |
| Time Up and Go Test | 6 week |
| Copd Assessment Test | 6 week |
| St George's Respiratory Questionnaire | 6 week |
| Hospital Anxiety and Depression Scale | 6 week |
| Medical Research Council Scale | 6 week |
| Short Physical Performance Battery | 6 week |
| International Physical Activity Questionnaire-Short Form | 6 week |
| Static Lung Volumes | 6 week |
Countries
Turkey (Türkiye)